FR Pharma Consulting ApS — Credit Rating and Financial Key Figures
CVR number: 44253569
Naverland 1 C, 2600 Glostrup
Income statement (kDKK)
2024 | |
|---|---|
| Fiscal period length | 12 |
| Net sales | |
| Gross profit | 1 566.09 |
| Employee benefit expenses | - 722.98 |
| EBIT | 843.10 |
| Other financial expenses | -1.25 |
| Pre-tax profit | 841.86 |
| Income taxes | - 186.98 |
| Net earnings | 654.88 |
Assets (kDKK)
2024 | |
|---|---|
| Intangible assets total | |
| Tangible assets total | |
| Investments total | |
| Long term receivables total | |
| Inventories total | |
| Current trade debtors | 206.25 |
| Short term receivables total | 206.25 |
| Cash and bank deposits | 1 101.18 |
| Cash and cash equivalents | 1 101.18 |
| Balance sheet total (assets) | 1 307.43 |
Equity and liabilities (kDKK)
2024 | |
|---|---|
| Share capital | 40.00 |
| Retained earnings | 203.35 |
| Profit of the financial year | 654.88 |
| Shareholders equity total | 898.23 |
| Non-current deferred tax liabilities | 186.98 |
| Non-current liabilities total | 186.98 |
| Current trade creditors | 7.33 |
| Short-term deferred tax liabilities | 57.55 |
| Other non-interest bearing current liabilities | 157.34 |
| Current liabilities total | 222.22 |
| Balance sheet total (liabilities) | 1 307.43 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.